M P9 (Pantoprazole sodium delayed release 40 mg)
Pill imprint M P9 has been identified as Pantoprazole sodium delayed release 40 mg.
Pantoprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; dumping syndrome; zollinger-ellison syndrome (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is not a controlled substance under the Controlled Substance Act (CSA).
- M P9
- 40 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Matrix Laboratories Limited
- National Drug Code (NDC):
- Inactive Ingredients:
methacrylic acid - ethyl acrylate copolymer (1:1) type a
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|51079-0051||UDL Laboratories Inc|
Note: Inactive ingredients may vary.
More about pantoprazole
- Pantoprazole delayed-release tablets
- Pantoprazole suspension
- Pantoprazole (Advanced Reading)
- Pantoprazole Intravenous (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.